产品标题 产品货号 产品规格 厂家
Human orosomucoid 2 (ORM2) from ORIGENE TECHNOLOGIESTP32321320 ugORIGENE TECHNOLOGIES
Human orosomucoid 2 (ORM2) from ORIGENE TECHNOLOGIESTP72082210 ugORIGENE TECHNOLOGIES
Human orthodenticle homeobox 2 (OTX2), transcript variant 1, full length from ORIGENE TECHNOLOGIESTP76015950 ugORIGENE TECHNOLOGIES
Human O-sialoglycoprotein endopeptidase (OSGEP) from ORIGENE TECHNOLOGIESTP30708920 ugORIGENE TECHNOLOGIES
Human OSM/Oncostatin M ELISA Kit from ORIGENE TECHNOLOGIESEA1003348x12 divisible stripORIGENE TECHNOLOGIES
Human OSM-R ELISA Kit (48-well) from ORIGENE TECHNOLOGIESEA10009348-well strip plateORIGENE TECHNOLOGIES
Human OSM-R ELISA Kit (96-well) from ORIGENE TECHNOLOGIESEA10009496-well strip plateORIGENE TECHNOLOGIES
Human osteoclast associated, immunoglobulin-like receptor (OSCAR), transcript variant 3 from ORIGENE TECHNOLOGIESTP32167520 ugORIGENE TECHNOLOGIES
Human osteoclast stimulating factor 1 (OSTF1) from ORIGENE TECHNOLOGIESTP32488520 ugORIGENE TECHNOLOGIES
Human osteoglycin (OGN), transcript variant 1 from ORIGENE TECHNOLOGIESTP32394820 ugORIGENE TECHNOLOGIES
Human osteoglycin (OGN), transcript variant 3 from ORIGENE TECHNOLOGIESTP31065120 ugORIGENE TECHNOLOGIES
Human osteopetrosis associated transmembrane protein 1 (OSTM1) from ORIGENE TECHNOLOGIESTP30987120 ugORIGENE TECHNOLOGIES
Human osteosarcoma amplified 9, endoplasmic reticulum associated protein (OS9), transcript variant 1 from ORIGENE TECHNOLOGIESTP31820620 ugORIGENE TECHNOLOGIES
Human osteosarcoma amplified 9, endoplasmic reticulum associated protein (OS9), transcript variant 4 from ORIGENE TECHNOLOGIESTP31682020 ugORIGENE TECHNOLOGIES
Human otoancorin (OTOA), transcript variant 1 from ORIGENE TECHNOLOGIESTP32114520 ugORIGENE TECHNOLOGIES
Human otoraplin (OTOR) from ORIGENE TECHNOLOGIESTP31098420 ugORIGENE TECHNOLOGIES
Human otoraplin (OTOR). from ORIGENE TECHNOLOGIESTP72334520 ugORIGENE TECHNOLOGIES
Human otospiralin (OTOS) from ORIGENE TECHNOLOGIESTP31125920 ugORIGENE TECHNOLOGIES
Human OTU domain containing 6B (OTUD6B) from ORIGENE TECHNOLOGIESTP30372220 ugORIGENE TECHNOLOGIES
Human OTU domain containing 7B (OTUD7B) from ORIGENE TECHNOLOGIESTP30993220 ugORIGENE TECHNOLOGIES
Human OTU domain containing 3 (OTUD3) from ORIGENE TECHNOLOGIESTP31898420 ugORIGENE TECHNOLOGIES
Human OTU domain containing 5 (OTUD5), transcript variant 1 from ORIGENE TECHNOLOGIESTP30089320 ugORIGENE TECHNOLOGIES
Human OTU domain, ubiquitin aldehyde binding 2 (OTUB2) from ORIGENE TECHNOLOGIESTP72021510 ugORIGENE TECHNOLOGIES
Human OTU domain, ubiquitin aldehyde binding 2 (OTUB2) from ORIGENE TECHNOLOGIESTP30965020 ugORIGENE TECHNOLOGIES
Human OTU domain, ubiquitin aldehyde binding 1 (OTUB1), transcript variant 1 from ORIGENE TECHNOLOGIESTP31064820 ugORIGENE TECHNOLOGIES
Human outer dense fiber of sperm tails 3-like 1 (ODF3L1) from ORIGENE TECHNOLOGIESTP30808520 ugORIGENE TECHNOLOGIES
Human outer dense fiber of sperm tails 3-like 2 (ODF3L2) from ORIGENE TECHNOLOGIESTP31508420 ugORIGENE TECHNOLOGIES
Human outer dense fiber of sperm tails 3 (ODF3) from ORIGENE TECHNOLOGIESTP31953320 ugORIGENE TECHNOLOGIES
Human outer dense fiber of sperm tails 4 (ODF4) from ORIGENE TECHNOLOGIESTP31129520 ugORIGENE TECHNOLOGIES
Human outer dense fiber of sperm tails 2 (ODF2), transcript variant 1 from ORIGENE TECHNOLOGIESTP30198520 ugORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma, metastatic, consistent with ovarian primary from ORIGENE TECHNOLOGIESCS7035765x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma, metastatic, consistent with ovarian primary from ORIGENE TECHNOLOGIESCS8043855x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma, metastatic, consistent with ovarian primary from ORIGENE TECHNOLOGIESCS6088925x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma, metastatic, consistent with ovarian primary from ORIGENE TECHNOLOGIESCS6160025x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary from ORIGENE TECHNOLOGIESCS8009275x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary from ORIGENE TECHNOLOGIESCS8009295x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary from ORIGENE TECHNOLOGIESCS8009315x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary from ORIGENE TECHNOLOGIESCS8115925x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary from ORIGENE TECHNOLOGIESCS6025765x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, clear cell from ORIGENE TECHNOLOGIESCS8034955x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, clear cell from ORIGENE TECHNOLOGIESCS8034965x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, clear cell from ORIGENE TECHNOLOGIESCS8034975x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, clear cell from ORIGENE TECHNOLOGIESCS8038025x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, clear cell from ORIGENE TECHNOLOGIESCS8038045x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, clear cell from ORIGENE TECHNOLOGIESCS5064795x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, clear cell from ORIGENE TECHNOLOGIESCS5101995x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, clear cell from ORIGENE TECHNOLOGIESCS6135585x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, clear cell from ORIGENE TECHNOLOGIESCS6266105x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, clear cell from ORIGENE TECHNOLOGIESCS6289185x5umORIGENE TECHNOLOGIES
Human Ovary; Adenocarcinoma of ovary, clear cell, metastatic from ORIGENE TECHNOLOGIESCS7045885x5umORIGENE TECHNOLOGIES
 |< < 3763 3764 3765 3766 3767 3768 3769 3770 3771 > >| 第 3770/6274 页